Doctors at NCR are conducting a study for adults who are overweight and want to lose weight. The study will evaluate a medication to determine how much weight a participant can lose in 1 1/2 years. All participants will receive instruction from a research dietitian and support to follow a calorie-reduced diet. The medication being tested in this study is called Semaglutide. Semaglutide was approved by the FDA in June 2022 for weight loss.
18 or older
- BMI over 30.0kg/m2
- History of at least one unsuccessful dietary effort to lose body weight
- Cannot be diabetic
- No treatment with glucose lowering agents in the last 90 days
- No treatment with other drugs in same class in last 180 days
- No history of cancer in the last 5 years
You will be reimbursed up to $975 if you complete the study visits
Want to participate? Fill out the interest form! Click to Call Us!